Karl Sotlar - Concepedia

Author

Karl Sotlar

Ludwig-Maximilians-Universität München ORCID

Also Known As

Franziska Ruëff, K Sotlar, K. Sotlar, KARL SOTLAR, Karl Sotlar, Karl Sotlar (23621), Sotlar, K, Sotlar, K., Sotlar, Karl, Tina Ristau

399

Publications

18.2K

Citations

H-Index

114

Concepts

All Affiliations

Ludwig-Maximilians-Universität München Medical University of Vienna University of Tübingen Heidelberg University University Hospital Heidelberg

About

Karl Sotlar is an author at Ludwig-Maximilians-Universität München specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	53	4.8K
2	Allergy	10	10	444
3	Health Sciences	6	6	340
4	Natural Sciences	2	2	262
5	Public Health	1	1	75

Karl Sotlar

134

Publications

11.6K

Citations

H-Index

Page 1

	Year	Citations
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes Peter Valent, Amy D. Klion, Hans‐Peter Horny, Journal of Allergy and Clinical Immunology Eosinophilic DisordersPsychiatryClinical EpidemiologyPediatricsEosinophilic Disorder	2012	747
Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal Peter Valent, Cem Akin, Michel Arock, International Archives of Allergy and Immunology	2011	623
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis Jason Gotlib, Hanneke C. Kluin‐Nelemans, Tracy I. George, New England Journal of Medicine	2016	465
Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells Sylvia Heink, Nir Yogev, Christoph Garbers, Nature Immunology InflammationCytokineAutoimmune DiseaseImmunologyImmune Regulation	2016	380
Detection and Typing of Human Papillomavirus by E6 Nested Multiplex PCR Karl Sotlar, David Diemer, A. Dethleffs, Journal of Clinical Microbiology	2004	315
Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia Sarah Ebinger, Erbey Ziya Özdemir, Christoph Ziegenhain, Cancer Cell	2016	277
Organization of Human Papillomavirus Productive Cycle during Neoplastic Progression Provides a Basis for Selection of Diagnostic Markers Kate Middleton, Woei Ling Peh, S A Southern, Journal of Virology	2003	254
Comprehensive mutational profiling in advanced systemic mastocytosis Juliana Schwaab, Susanne Schnittger, Karl Sotlar, Blood	2013	252
Progression-Specific Genes Identified by Expression Profiling of Matched Ductal Carcinomas <i>In situ</i> and Invasive Breast Tumors, Combining Laser Capture Microdissection and Oligonucleotide Microarray Analysis Christina S. Schuetz, Michael Bonin, Susan E. Clare, Cancer Research	2006	239
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis Mohamad Jawhar, Juliana Schwaab, Susanne Schnittger, Leukemia Additional MutationsMast Cell DisorderSystemic MastocytosisPathogenesisImmunology	2015	218

Page 1